SCHEMBL18190894

SCHEMBL18190894

Cc1ccccc1N(C)[C]N(C)c1ccccc1C

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
ACHE P22303 2/20 0.43
SIGMAR1 Q99720 1/20 0.40
HSD17B1 P14061 2/20 0.36
HSD17B2 P37059 2/20 0.36
LMNA P02545 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CYP3A4 P08684 3/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961573 0.81 TSHR (0.43) TSHRACHESIGMAR1HSD17B1HSD17B2
SCHEMBL7129369 0.81 TSHR (0.39) TSHRACHESIGMAR1LMNAALDH1A1
SCHEMBL2093822 0.81 TSHR (0.39) TSHRACHESIGMAR1HSD17B1HSD17B2
SCHEMBL29239 0.76 TSHR (0.50) TSHRACHESIGMAR1HSD17B1HSD17B2
SCHEMBL29435133 0.76 TSHR (0.50) TSHRACHESIGMAR1HSD17B1HSD17B2
SCHEMBL2620728 0.76 ACHE (0.50) TSHRACHESIGMAR1LMNAALDH1A1
Hydrochloric Acid SCHEMBL6421167 0.74 TSHR (0.47) TSHRACHESIGMAR1HSD17B1HSD17B2
SCHEMBL21065735 0.74 TSHR (0.47) TSHRACHESIGMAR1HSD17B1HSD17B2
Hydrochloric Acid SCHEMBL2869837 0.74 TSHR (0.47) TSHRACHESIGMAR1HSD17B1HSD17B2
Lithium Ion SCHEMBL19732623 0.74 TSHR (0.47) TSHRACHESIGMAR1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3265448-A1 RILUZOLE PRODRUGS AND THEIR USE Biohaven Pharmaceutical Holding Company Ltd. (US) 2018-01-10 EP disclosed
WO-2016140879-A9 RILUZOLE PRODRUGS AND THEIR USE BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. (US) 2016-11-03 WO disclosed